Overall median graft survival was 5.6?years. methylprednisolone pulse therapy); and group 2 received?supportive treatment. Results From February 2009 to December 2017, a total of 82 patients with biopsy-proven chronic antibody mediated rejection were identified. Kaplan-Meier analysis of death-censored graft survival showed a worse survival in group 2 (valuetransplant glomerulopathy, interstitial fibrosis, tubular atrophy, mesangial matrix […]